Dicumarol
(DOBMPNYZJYQDGZ-UHFFFAOYSA-N)
Structure
- SMILES
- O=c1oc2ccccc2c(c1Cc1c(=O)oc2c(c1O)cccc2)O
- Type(s)
- Approved
- ATC code(s)
- B01AA01
- Molecular Formula:
- C19H12O6
- Molecular Weight:
- 336.295
- Log P:
- 2.9014
- Hydrogen Bond Acceptor:
- 6
- Hydrogen Bond Donor:
- 2
- TPSA:
- 100.88
- CAS Number(s):
- 66-76-2
Synonym(s)
1.
Dicumarol
2.
Bishydroxycoumarin
3.
Dicoumarin
4.
Dicoumarol
External Link(s)
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Drug ineffective | FAERS: 1 | US FAERS | |
| 2 | Petechiae | FAERS: 1 | US FAERS | |
| 3 | Stillbirth | FAERS: 1 | US FAERS | |
| 4 | Abdominal Pain | Canada Vigilance: 2 | Canada Vigilance | |
| 5 | Abdominal discomfort | Canada Vigilance: 1 | Canada Vigilance | |
| 6 | Asthenia | Canada Vigilance: 1 | Canada Vigilance | |
| 7 | Back Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 8 | Blindness | 4112318 | CTD | |
| 9 | Cardiac Tamponade | 6184935 | CTD | |
| 10 | Cerebral Hemorrhage | 54935 1374271 | CTD | |
| 11 | Chest Pain | Canada Vigilance: 1 | Canada Vigilance | |
| 12 | Cholestasis | 9548270 | CTD | |
| 13 | Corneal edema | 4112318 | CTD | |
| 14 | Diarrhea | 4173338 | CTD | |
| 15 | Dizziness | Canada Vigilance: 1 | Canada Vigilance | |
| 16 | Ecchymosis | Canada Vigilance: 1 | Canada Vigilance | |
| 17 | Epistaxis | Canada Vigilance: 3 | Canada Vigilance | |
| 18 | Erythema Multiforme | Canada Vigilance: 1 | Canada Vigilance | |
| 19 | Eye pain | 4112318 | CTD | |
| 20 | Factor II deficiency | Canada Vigilance: 1 | Canada Vigilance | |
| 21 | Hematuria | 4171018 | CTD | |
| 22 | Hemorrhage | 4112318 | CTD | |
| 23 | Hypotension | Canada Vigilance: 1 | Canada Vigilance | |
| 24 | Kidney Diseases | 4171018 21613233 | CTD | |
| 25 | Liver Failure, Acute | 9548270 | CTD | |
| 26 | Malaise | Canada Vigilance: 1 | Canada Vigilance | |
| 27 | Myalgia | Canada Vigilance: 1 | Canada Vigilance | |
| 28 | Myocardial Infarction | 4173338 | CTD | |
| 29 | Nausea | Canada Vigilance: 1 | Canada Vigilance | |
| 30 | Ocular Hypertension | 4112318 | CTD | |
| 31 | Pericardial effusion | 6184935 | CTD | |
| 32 | Postoperative Complications | 54935 | CTD | |
| 33 | Prothrombin level decreased | Canada Vigilance: 2 | Canada Vigilance | |
| 34 | Pulmonary Embolism | 4112318 | CTD | |
| 35 | Thromboembolism | 54935 | CTD | |
| 36 | Thrombosis | 10831996 | CTD | |
| 37 | Vomiting | Canada Vigilance: 2 | Canada Vigilance | |
| 38 | melanoma | 20685355 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.